VRCA Verrica Pharmaceuticals Inc.

10.82
-0.27  -2%
Previous Close 11.09
Open 11.12
Price To Book 2.88
Market Cap 278034734
Shares 25,696,371
Volume 51,294
Short Ratio
Av. Daily Volume 53,247

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trials met primary endpoints - January 9, 2019. Data to be presented at AAD meeting March 2, 2019 3:30pm.
VP-102
Molluscum contagiosum
Phase 2 data due 2Q 2019.
VP-102
Common warts
Phase 2 data completed - September 12, 2018.
VP-102
Molluscum contagiosum
Phase 2 trial to be initiated 1H 2019.
VP-102
Genital warts